About Drugs in Context

Drugs in Context is an open access, peer-reviewed, continuous publication of international standing. It is a member of the Directory of Open Access Journals (https://doaj.org/). It is listed on PubMed and all articles are free-to-view/download immediately on PubMed Central.

Metrics: SJR/Scimago: Q1 title; H index = 10; SJR = 1.193. Equivalent Impact Factor = 3.07.

Articles: we publish high-quality, peer-reviewed original research papers and topical review articles covering the latest evidence and innovations in drug treatment across all therapeutic areas. Other article types are considered.

Peer review: we conduct single-blind external peer review on all manuscripts with comments from at least two peer reviewers. Our aim is to obtain a first editorial decision within 3 weeks of manuscript submission and online publication within 3 weeks of acceptance.

Submit your article: check the 'AUTHORS' pages for full information.

Latest Article

Agents to treat BRAF-mutant lung cancer

Jean G Bustamante Alvarez MD, MS, Gregory A Otterson MD

Articles 2018

Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review

Sandra Ly MD, Jean Michel Amici MD

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Yue Zhao MD, Rishi P Singh MD

Advances in the use of PARP inhibitor therapy for breast cancer

Kelly E McCann MD, PhD, Sara A Hurvitz MD

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment

Sarah L Anderson PharmD, Joel C Marrs PharmD

Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors

Daniel I G Cubero MD, PhD, Beatrice Martinez Zugaib Abdalla MD, Jean Schoueri, Fabio Iazetti Lopes, Karine Corcione Turke, Jose Guzman MD, Auro Del Giglio MD, PhD, Carlos D’Apparecida Santos Machado Filho MD, PhD, Vanessa Salzano MD, Dolores Gonzalez Fabra MD